Detoxa Book – Mycotoxins: Prevalence in Latin America 2020

BV Science, the US company of Vetanco SA and Dr. Bata Ltd., presents the third edition of the Detoxa [...]

Vetanco´s corporate site adds access to its Colombia subsidiary site

Vetanco, an international veterinary laboratory that for over 30 years has been developing, manufacturing and [...]

Vetanco at the CRWAD Conference

Our specialists participated in the “Conference of Research Workers in Animal Diseases 2020” held virtually [...]

INCUINTA and Bioinnovo apply their knowledge to fight COVID19

Argentine researchers used two different platforms to neutralize the virus with “nanobodies” derived from llamas [...]

Bioinnovo will increase production of the vaccine against Bovine Viral Diarrhea Virus

Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry [...]

A new achievement in the fight against COVID-19

A multidisciplinary team, where Bioinnovo SA participates, developed IgY avian antibodies that neutralize the COVID-19 [...]

Vetanco and Bioinnovo congratulate the company Algenex on a new achievement

Algenex, the Spanish company delivering recombinant technologies, a key factor for the development of Vedevax BLOCK, [...]

Bovine Viral Diarrhea: the Argentinian vaccine will be sold in Peru

The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control [...]

100% Argentinian technology for the COVID-19 test

Specialists of the National Institute of Industrial Technology (INTI) and the national company Ivema Desarrollos designed an [...]

Vetanco develops an alliance with the UDESC

The constant Research and Development is a principle of Vetanco DNA and the reason why [...]